ImmunoCellular Therapeutics Ltd. President and CEO Manish Singh rings The Opening BellSM. The company is visiting the NYSE to commemorate its May 30, 2012 listing on NYSE MKT. ImmunoCellular trades under the ticker symbol IMUC.
Watch the video of the ringing.
About ImmunoCellular Therapeutics, Ltd.
ImmunoCellular Therapeutics, Ltd. is a Los Angeles-based clinical stage company that is developing immune-based therapies for the treatment of brain and other cancers. The Company has commenced a Phase II trial of its lead product candidate, ICT-107, a dendritic cellbased vaccine targeting multiple tumor-associated antigens for glioblastoma. To learn more about IMUC, please visit www.imuc.com.